EN 中文
Home Strategic Partnerships News Contact us
TOTAL:83 NEWS
Zhaoke Ophthalmology Announces NMPA Acceptance of New Drug Application for NVK002 (Atropine Sulphate Eye Drops 0.02%) for the Treatment of Myopia Progression in Children
read
2025-07-09
132
Zhaoke Ophthalmology and Jamjoom Pharma Forge Landmark Partnership to Revolutionize Dry Eye Treatment in the Middle East
read
2025-06-30
277
Zhaoke Ophthalmology Expands its Footprint in the U.S. Partnering with Leading US Pharma, Somerset Therapeutics LLC
read
2025-06-25
310
Zhaoke Ophthalmology’s Biologics License Application for TAB014 for wAMD Accepted for Review by the NMPA
read
2025-06-12
459
Zhaoke Ophthalmology Obtains FDA Clearance for CsA Ophthalmic Gel’s IND Application in the U.S.
read
2025-06-04
563
>

Guangzhou Headquarters
Tel: 020-39062828
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat